ArticlePLOS digital health2023
AutoPrognosis 2.0: Democratizing diagnostic and prognostic modeling in healthcare with automated machine learning.
Article in PLOS digital health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 37 citations in OpenAlex.
- Clinician-accessible automated machine learning in oral healthcare: A systematic review.The Japanese dental science review · 2026Review
- Automated Machine Learning Frameworks for Radiomics: Comparative Evaluation Study.JMIR formative research · 2026Article
- Review
- Interpretable Feature Selection and Hybrid Deep Learning Models for Depressive Symptoms Prediction from Wearable Device Data.Journal of medical systems · 2026Article
- Morphological risk factors of parent arteries in intracranial aneurysm formation: an interpretable machine learning analysis.Neuroradiology · 2026Article
- Article
- Artificial Intelligence in Predictive Healthcare: A Systematic Review.Journal of clinical medicine · 2025Review
- Maturity Framework for Operationalizing Machine Learning Applications in Health Care: Scoping Review.Journal of medical Internet research · 2025Article
- RadiomiX for Radiomics Analysis: Automated Approaches to Overcome Challenges in Replicability.Diagnostics (Basel, Switzerland) · 2025Article
- Characterizing the role of early life factors in machine learning-based multimorbidity risk prediction.PLOS digital health · 2025Article
- Redefining digital health interfaces with large language models.Frontiers in artificial intelligence · 2025Article
- Toward real-world deployment of machine learning for health care: External validation, continual monitoring, and randomized clinical trials.Health care science · 2024Article
- Article
- Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.PLoS medicine · 2023Article
- External validity of machine learning-based prognostic scores for cystic fibrosis: A retrospective study using the UK and Canadian registries.PLOS digital health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diagnostic and prognostic models are increasingly important in medicine and inform many clinical decisions. Recently, machine learning approaches have shown improvement over conventional modeling techniques by better capturing complex interactions between patient covariates in a data-driven manner. However, the use of machine learning introduces technical and practical challenges that have thus far restricted widespread adoption of such techniques in clinical settings. To address these challenges and empower healthcare professionals, we present an open-source machine learning framework, AutoPrognosis 2.0, to facilitate the development of diagnostic and prognostic models. AutoPrognosis leverages state-of-the-art advances in automated machine learning to develop optimized machine learning pipelines, incorporates model explainability tools, and enables deployment of clinical demonstrators, without requiring significant technical expertise. To demonstrate AutoPrognosis 2.0, we provide an illustrative application where we construct a prognostic risk score for diabetes using the UK Biobank, a prospective study of 502,467 individuals. The models produced by our automated framework achieve greater discrimination for diabetes than expert clinical risk scores. We have implemented our risk score as a web-based decision support tool, which can be publicly accessed by patients and clinicians. By open-sourcing our framework as a tool for the community, we aim to provide clinicians and other medical practitioners with an accessible resource to develop new risk scores, personalized diagnostics, and prognostics using machine learning techniques. Software: https://github.com/vanderschaarlab/AutoPrognosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.